Stay updated on Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.

Latest updates to the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.6.5 has been added to the page. The Plain Language Summary section was removed and the Revision: v3.6.4 entry was deleted, affecting how the trial information is presented.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision metadata on the page was updated to v3.6.4, replacing the previous v3.6.3. This reflects a new release/version of the page's underlying software.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision: v3.6.3 replaces the previous Revision: v3.6.2 on the page, indicating a minor page update.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision label on the page updated from v3.6.0 to v3.6.2, representing an administrative update to the page template. The study data and core information shown remain unchanged.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page adds user-help sections such as How to Read a Study Record, Common Questions, and How to Join a Study, and updates recruitment status to No longer looking for participants. The Intervention/Treatment heading formatting is harmonized to Intervention/Treatment and the revision label updated to Revision: v3.6.0.SummaryDifference0.2%

- Check75 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page. This change reflects an update to the page's version metadata rather than content changes.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.